This is the authors' abstract. We don't add key points for this paper.
A new FK506 analogue, 9-deoxo-prolyl-FK506, was discovered and purified from the fkbD (responsible for C-9 oxidation) deletion mutant of Streptomyces sp. KCTC11604BP, and its biological activities were evaluated.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shinde et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: